Bristol-Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Capital expenditures increased by 5% from FY24 to FY25.
Current Price
$58.22
-3.91%GoodMoat Value
$98.93
69.9% undervaluedBristol-Myers Squibb Company (BMY) Stock Chart
BMY Interactive Stock Chart
Interactive stock chart for Bristol-Myers Squibb Company (BMY) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $58.22. 52-week high: $61.72. 52-week low: $41.66. 50-day moving average: $59.16. 200-day moving average: $51.03.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for BMY. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Bristol-Myers Squibb Company's investment potential.